Plain-English translation of NCT02491840 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is looking for biological markers—signs in your tumor cells—that can predict whether standard chemotherapy will work well for stomach cancer. Researchers will examine a small tissue sample from your tumor to identify which patients are likely to respond well to treatment and which may need a different approach. This information could help doctors make better decisions about your care.
Some people with stomach cancer don't respond well to chemotherapy, and going through treatment that won't help can delay surgery and worsen outcomes. By finding biological markers that predict who will and won't respond, doctors hope to spare patients from ineffective treatments and choose the best approach from the start.
You likely qualify if…
You likely don't qualify if…
You will have a small tissue sample (biopsy) taken from your tumor, which is typically collected as part of your regular cancer diagnosis. Researchers will examine this sample in the laboratory to identify biological markers and genetic changes. You will also be asked to complete questionnaires about your lifestyle and quality of life, and your doctors will track how you respond to chemotherapy and how long you survive over a 5-year period.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
France